Literature DB >> 12093885

The choreography of cyclooxygenases in the kidney.

G A FitzGerald1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12093885      PMCID： PMC151038          DOI： 10.1172/JCI16044

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  22 in total

Review 1.  Why there are two cyclooxygenase isozymes.

Authors:  W L Smith; R Langenbach
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  The coxibs, selective inhibitors of cyclooxygenase-2.

Authors:  G A FitzGerald; C Patrono
Journal:  N Engl J Med       Date:  2001-08-09       Impact factor: 91.245

3.  Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor.

Authors:  C R Kennedy; Y Zhang; S Brandon; Y Guan; K Coffee; C D Funk; M A Magnuson; J A Oates; M D Breyer; R M Breyer
Journal:  Nat Med       Date:  1999-02       Impact factor: 53.440

Review 4.  Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.

Authors:  A Whelton; C J Maurath; K M Verburg; G S Geis
Journal:  Am J Ther       Date:  2000-05       Impact factor: 2.688

5.  Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo.

Authors:  L P Audoly; B Rocca; J E Fabre; B H Koller; D Thomas; A L Loeb; T M Coffman; G A FitzGerald
Journal:  Circulation       Date:  2000-06-20       Impact factor: 29.690

6.  Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2.

Authors:  N Ueno; M Murakami; T Tanioka; K Fujimori; T Tanabe; Y Urade; I Kudo
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

7.  Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2.

Authors:  G E Caughey; L G Cleland; J R Gamble; M J James
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

Review 8.  NAD(P)H oxidase: role in cardiovascular biology and disease.

Authors:  K K Griendling; D Sorescu; M Ushio-Fukai
Journal:  Circ Res       Date:  2000-03-17       Impact factor: 17.367

9.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

10.  Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics.

Authors:  L P Audoly; X Ruan; V A Wagner; J L Goulet; S L Tilley; B H Koller; T M Coffman; W J Arendshorst
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-01       Impact factor: 4.733
View more
  10 in total

1.  Prostaglandin E(2) is crucial in the response of podocytes to fluid flow shear stress.

Authors:  Tarak Srivastava; Ellen T McCarthy; Ram Sharma; Patricia A Cudmore; Mukut Sharma; Mark L Johnson; Lynda F Bonewald
Journal:  J Cell Commun Signal       Date:  2010-04-08       Impact factor: 5.782

Review 2.  Hyperfiltration-associated biomechanical forces in glomerular injury and response: Potential role for eicosanoids.

Authors:  Mukut Sharma; Ram Sharma; Ellen T McCarthy; Virginia J Savin; Tarak Srivastava
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-17       Impact factor: 3.072

Review 3.  The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.

Authors:  Tilo Grosser; Emanuela Ricciotti; Garret A FitzGerald
Journal:  Trends Pharmacol Sci       Date:  2017-06-23       Impact factor: 14.819

4.  Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function.

Authors:  Yan Cheng; Miao Wang; Ying Yu; John Lawson; Colin D Funk; Garret A Fitzgerald
Journal:  J Clin Invest       Date:  2006-04-13       Impact factor: 14.808

5.  Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice.

Authors:  Ying Yu; Jane Stubbe; Salam Ibrahim; Wen-liang Song; Emer M Smyth; Emer M Symth; Colin D Funk; Garret A FitzGerald
Journal:  Circ Res       Date:  2009-11-25       Impact factor: 17.367

6.  Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.

Authors:  Dairong Wang; Vickas V Patel; Emanuela Ricciotti; Rong Zhou; Mark D Levin; Ehre Gao; Zhou Yu; Victor A Ferrari; Min Min Lu; Junwang Xu; Hualei Zhang; Yiqun Hui; Yan Cheng; Nataliya Petrenko; Ying Yu; Garret A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-17       Impact factor: 11.205

7.  Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis.

Authors:  Ying Yu; Margaret B Lucitt; Jane Stubbe; Yan Cheng; Ulla G Friis; Pernille B Hansen; Boye L Jensen; Emer M Smyth; Garret A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-24       Impact factor: 11.205

Review 8.  Balancing gastroprotection and cardioprotection with selective cyclo-oxygenase-2 inhibitors: clinical implications.

Authors:  Emma A Meagher
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 9.  Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease.

Authors:  Mukut Sharma; Vikas Singh; Ram Sharma; Arnav Koul; Ellen T McCarthy; Virginia J Savin; Trupti Joshi; Tarak Srivastava
Journal:  Biomedicines       Date:  2022-02-09

Review 10.  Use of NSAIDs in treating patients with arthritis.

Authors:  Leslie J Crofford
Journal:  Arthritis Res Ther       Date:  2013-07-24       Impact factor: 5.156
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.